the major risk factors for infection in cll and exploring strategies to mitigate risk
Published 3 months ago • 143 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
3:41
the cll treatment infection model: identifying patients with cll at high risk of infections
-
2:55
a model including cd49d expression to predict outcomes in patients with cll treated with ibrutinib
-
0:58
infection risk associated with btkis in cll: a meta-analysis of clinical trials
-
2:57
the importance of analyzing cytogenetic risk in patients with aml undergoing haploidentical sct
-
2:11
genetic testing to risk stratify a patient with cll and aid in treatment decisions
-
3:09
overcoming challenges with targeted therapies for cll: high-risk mutations and btki resistance
-
1:40
prophylactic tocilizumab to mitigate crs in patients with r/r myeloma receiving talquetamab
-
13:50
chronic lymphocytic leukemia (cll)
-
6:36
anthony mato: loxo-305 demonstrates efficacy in patients with cll/sll
-
3:47
the impact of cytogenetic-risk stratification on aml outcomes
-
1:13
monitoring patients with cll on ibrutinib-based therapies
-
6:19
machine learning to identify cll patients at high risk of infection
-
2:34
sequencing of therapies in patients with r/r cll
-
1:26
incidence and risk factors associated with vod/sos in younger vs older adults after sct
-
2:18
tools to improve the outcomes of patients with cll affected by covid-19
-
2:36
treatment approaches to cll with high-risk molecular features
-
1:59
assessing if a patient with dlbcl is responding to treatment using pet-ct and novel assays
-
2:59
the tests that are needed to make a definitive diagnosis of cll
-
1:18
involving the patient in treatment decisions for cll
-
1:14
cll: ighv mutational status
-
1:39
the importance of diagnostic testing in cll